Could this be the biggest cannabis power play ever?
Canopy Growth, Aurora Cannabis and Aphria Inc. (the “Big 3”) are set to make a big splash in Germany – by far Europe’s largest emerging marketplace for medical cannabis.
As they roll out their aggressive expansions into Germany, investors and medical patients alike all across Europe are keenly following these game-changing developments.
So the management teams of the Big 3 (which now have a combined market capitalization of around $25 billion) will meet face to face with around 300 private and institutional investors next month at the most prestigious cannabis event of the year.
They will present at the inaugural Canadian Cannabis Capital Markets Conference in Frankfurt on October 21-22 at the Hilton Frankfurt City Centre.
Keynote speakers include Bruce Linton, CEO of Canopy Growth, the world’s dominant cannabis grower with operations on five continents. Yet the company did not even exist five years ago. Now it has a market capitalization of CDN $15 billion – bigger than Lufthansa’s.
Even more extraordinary is the fact that Canopy Growth (TSX: WEEK) (NYSE: CGC) has seen its share price appreciate in value about 25 times since trading as low at $2.50 about 30 months ago.
Aphria (TSX: APH) has also experienced a similarly meteoric rise during the same time frame, rising from around $1.50 a share to around $20.
Vic Neufeld, the CEO of Aphria Inc. (which now has a $5 billion market capitalization) will be speaking at the conference about the secret of his company’s amazing success.
Also, Cam Battley from Aurora Cannabis (which has a market capitalization of around $9 billion) will explain his company’s strategy to become the world’s dominant cannabis company. He will also discuss why he sees Germany as being an especially important medical cannabis market for Aurora (TSX: ACB).
Other fast-emerging medical cannabis companies that will present include such high-flyers as The Green Organic Dutchman (TSX: TGOD), TSX-listed HEXO Corp. (formerly Hydropothecary), Emerald Heath Therapeutics (TSX.V: EMH) and Maricann Group (CSE: MARI).
These are Some of the World’s’ Best Performing Stocks
All these companies represent the best-in-class among Canada’s dozens of cannabis stocks. Interestingly, these blue-chip cannabis stocks have outperformed all other cannabis stocks in 2018.
This is clearly demonstrated by the exceptional performance of the www.3cindex.ca in recent weeks (a blue-chip index featuring all of these best-in-class companies). The index has appreciated from 2274 points in mid August to an all-time high of 4,030 on Sept 12th before backing off to around 3,800 points.
This currently represents an average gain per company of over 60%, or 75% at the market peak – and all within the last month!
Click to enlarge.
Many investors will be at the conference to identify the stocks that have not yet made huge moves to the upside. Some of these relatively inexpensive stocks are on-track to become the star performers of tomorrow.
Most importantly, these are companies that are not anywhere near as far along the developmental growth curve as the likes of Aurora, Aphria or Canopy Growth. So, their more modest share prices reflect this reality.
Yet some of these companies are themselves already aggressively moving into European and Latin American markets for medical cannabis. So they too are expected to become well-known global brands.
Other conference speakers will include some of the most influential people in Germany at the forefront of the movement to make medicinal cannabis available to millions of German medical patients.
Attendees will find out how and why this non-toxic and non-addictive alternative to many problematic pharmaceutical drugs is heralding a global cultural revolution.
Conference highlights include:
LISTEN TO THE MOST DYNAMIC AND SUCCESSFUL LEADERS IN THE CANNABIS INDUSTRY
- HEAR THE SECRETS OF CANOPY GROWTH’S AMAZING SUCCESS
- DISCOVER THE EMERGING SUCCESS STORIES OF TOMORROW
- FIND OUT WHICH CANNABIS STOCKS CONSISTENTLY OUTPERFORM ALL OTHERS
- LEARN ABOUT THE FUTURE OF MEDICAL CANNABIS IN GERMANY
- SEE WHY MEDICAL CANNABIS IS SWEEPNIG THE PLANET
- MIX IT UP WITH BOTH PROFESSIONAL AND SOCIAL INTERACTIONS
- ENJOY A SUNDAY EVENING GALA FEATURING WORLD-CLASS ENTERTAINMENT
If you’re in Canada and would love to see these two days of presentations from Canada’s best-in-class cannabis companies, don’t worry. Stockhouse has got you covered.
A broadcast of the event will be available exclusively for Stockhouse readers to enjoy from the comfort of their living rooms soon after the event. Stay tuned for details. Stockhouse will keep you updated on the date and time of this special broadcast.
For more information, check out the web site at www.3cmconference.com
About the Author: Marc Davis has a deep background in the capital markets spanning 30 years, having mostly worked as an analyst and stock market commentator. He is also a longstanding financial journalist. Over the years, his articles have also appeared in dozens of digital publications worldwide. They include USA Today, CBS Money Watch, Investors’ Business Daily, the Financial Post, Reuters, National Post, Google News, Barron’s, China Daily, Huffington Post and AOL.
FULL DISCLOSURE: The Green Organic Dutchman, HEXO Corp., Emerald Heath, and Maricann Group are paid clients of Stockhouse Publishing.